Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SF3B
|
|||
Former ID |
DNC006487
|
|||
Drug Name |
2-butylamido-5-sulfonamidoindane
|
|||
Synonyms |
CHEMBL208531; 2-butylamido-5-sulfonamidoindane; Indanesulfonamide Derivative 12f; N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)pentanamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H20N2O3S
|
|||
Canonical SMILES |
CCCCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N
|
|||
InChI |
1S/C14H20N2O3S/c1-2-3-4-14(17)16-12-7-10-5-6-13(20(15,18)19)9-11(10)8-12/h5-6,9,12H,2-4,7-8H2,1H3,(H,16,17)(H2,15,18,19)
|
|||
InChIKey |
VPKYLHQTQYEJLJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.